Literature DB >> 24762270

Primary haemostasis: newer insights.

M C Berndt1, P Metharom, R K Andrews.   

Abstract

At the same time as biophysical and omics approaches are drilling deeper into the molecular details of platelets and other blood cells, as well as their receptors and mechanisms of regulation, there is also an increasing awareness of the functional overlap between human vascular systems. Together, these studies are redefining the intricate networks linking haemostasis and thrombosis with inflammation, infectious disease, cancer/metastasis and other vascular pathophysiology. The focus of this state-of-the-art review is some of the newer advances relevant to primary haemostasis. Of particular interest, platelet-specific primary adhesion-signalling receptors and associated activation pathways control platelet function in flowing blood and provide molecular links to other systems. Platelet glycoprotein (GP)Ibα of the GPIb-IX-V complex and GPVI not only initiate platelet aggregation and thrombus formation by primary interactions with von Willebrand factor and collagen, respectively, but are also involved in coagulation, leucocyte engagement, bacterial or viral interactions, and are relevant as potential risk markers in a range of human diseases. Understanding these systems in unprecedented detail promises significant advances in evaluation of individual risk, in new diagnostic or therapeutic possibilities and in monitoring the response to drugs or other treatment.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Clec-2; arterial thrombosis; glycoprotein Ib; glycoptrotein VI; venous thrombosis; von Willebrand factor

Mesh:

Substances:

Year:  2014        PMID: 24762270     DOI: 10.1111/hae.12427

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  28 in total

1.  Quantitative analysis of platelets aggregates in 3D by digital holographic microscopy.

Authors:  Karim Zouaoui Boudejltia; Daniel Ribeiro de Sousa; Pierrick Uzureau; Catherine Yourassowsky; David Perez-Morga; Guy Courbebaisse; Bastien Chopard; Frank Dubois
Journal:  Biomed Opt Express       Date:  2015-08-25       Impact factor: 3.732

2.  Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains.

Authors:  Amit Prabhakar; Tathagata Chatterjee; Nitin Bajaj; Tarun Tyagi; Anita Sahu; Neha Gupta; Babita Kumari; Velu Nair; Bhuvnesh Kumar; Mohammad Zahid Ashraf
Journal:  Blood Adv       Date:  2019-11-26

Review 3.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

4.  Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects.

Authors:  Constance C F M J Baaten; Frauke Swieringa; Tomasz Misztal; Tom G Mastenbroek; Marion A H Feijge; Paul E Bock; Marjo M P C Donners; Peter W Collins; Renhao Li; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Blood Adv       Date:  2018-09-25

Review 5.  Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.

Authors:  Reheman Adili; Megan Hawley; Michael Holinstat
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-25       Impact factor: 3.072

6.  Leucocyte cytokines dominate platelet cytokines overtime in non-leucoreduced platelet components.

Authors:  Chaker Aloui; Tahar Chakroun; Antoine Prigent; Saloua Jemni-Yacoub; Fabrice Cognasse; Sandrine Laradi; Olivier Garraud
Journal:  Blood Transfus       Date:  2016-09-08       Impact factor: 3.443

Review 7.  Platelets and galectins.

Authors:  Mirta Schattner
Journal:  Ann Transl Med       Date:  2014-09

8.  Hemizygosity for the gene encoding glycoprotein Ibβ is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome.

Authors:  N M J Zwifelhofer; R S Bercovitz; L A Weik; A Moroi; S LaRose; P J Newman; D K Newman
Journal:  J Thromb Haemost       Date:  2019-01-22       Impact factor: 5.824

9.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

10.  Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.

Authors:  Reheman Adili; Madeline Jackson; Livia Stanger; Xiangrong Dai; Mandy Li; Benjamin Xiaoyi Li; Michael Holinstat
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.